ADMA NASDAQ
ADMA Biologics, Inc.
1W: -0.5%
1M: -22.7%
3M: -47.5%
YTD: -52.7%
1Y: -58.6%
3Y: +107.3%
5Y: +391.9%
$8.24
-0.22 (-2.60%)
Weekly Expected Move ±9.6%
$7
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$510M
Revenue
+11.0% YoY
$165M
Net Income
-20.0% YoY
$108M
Free Cash Flow
+19.1% YoY
70.5%
Gross Margin
43.9%
Op. Margin
39.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE40.0%
ROA29.7%
ROIC35.3%
Valuation
P/E11.8
P/B5.0
EV/EBITDA10.1
Leverage
Debt/Equity0.17
Current Ratio6.71
Interest Cov.28.3x
Quality Scores
Piotroski F6/9
Altman Z11.13
Beneish M-0.39